Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WXSH0493 in Hyperuricemia With or Without Gout
CTR20232057Phase 2Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WXSH0493 in hyperuricemia, gout, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Jul 2023; status: completed.
02
Drugs
WXSH0493
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on CTR20232057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232057.